Quick Facts
Founded
2012 (14 years)
Headquarters
Singapore, Singapore
Type
commercial
Primary Focus
surgical robots
About Biobot Surgical
Biobot Surgical develops the Mona Lisa robotic system for targeted prostate biopsies & soft tissue ablation, pioneering robotic transperineal procedures. They differentiate through 1.0mm robotic accuracy & have completed over 25,000 procedures globally with 50+ units installed. Regulatory clearances include FDA, CE, & HSA, and they’ve expanded to markets in the US, China, Australia, & Europe. Recent developments include CE certification for the Mona Lisa 2.0 [Tx] system.
Key Products & Services
Mona Lisa, Mona Lisa 2.0 [Tx], Mona Lisa [Dx]
Quick Links
Location
Open in Google MapsSee incorrect or outdated information? Suggest an edit →
Similar Companies
Companies with similar characteristics to Biobot Surgical
A
Ailytics
Singapore, Singapore
Same country Same city Same category
$4M raised
B
BeeX
Singapore, Singapore
Same country Same city Same category
CenoBots
Singapore, Singapore
Same country Same city Same category
E
EndoMaster
Singapore, Singapore
Same country Same city Same category
Eureka Robotics
Singapore, Singapore
Same country Same city Same category
NDR Medical Technology
Singapore, Singapore
Same country Same city Same category
$10M raised